STEPHEN R HAMMES, MD PHD
Osteopathic Medicine at Elmwood Ave, Rochester, NY

License number

New York 251521

Personal information

See more information about STEPHEN R HAMMES at radaris.com

Name

Address

Phone

Stephen Hammes, age 60

154 Clover Hills Dr, Rochester, NY 14618

Stephen Hammes

Rochester, NY

(585) 244-0903

Professional information

See more information about STEPHEN R HAMMES at trustoria.com

Chief, Division Of Endocrinology At University Of Rochester Medical Center

Position:

Chief, Division of Endocrinology at University of Rochester Medical Center

Location:

Rochester, New York Area

Industry:

Hospital & Health Care

Work:

University of Rochester Medical Center - Chief, Division of Endocrinology UT Southwestern Medical Center at Dallas 2006 - 2009 - Associate Professor UT Southwestern Medical Center at Dallas 1999 - 2006 - Assistant Professor UCSF Medical Center 1995 - 1999 - Endocrinology Fellow UCSF Medical Center 1993 - 1995 - Medicine Resident

Education:

Duke University School of Medicine 1985 - 1993
MD, PhD, Immunology Cornell University 1981 - 1985
BA, Chemistry

Dr. Stephen R Hammes, Rochester NY - MD (Doctor of Medicine)

Specialties:

Endocrinology, Diabetes & Metabolism

Address:

Endo Prctc Grp Strn Mem Hosp
601 Elmwood Ave, Rochester 14642
(585) 275-2901 (Phone)
University Rochester Med Ct-End
601 Elmwood Ave SUITE 693, Rochester 14642
(585) 275-2901 (Phone)

Certifications:

Diabetes, Metabolism & Endocrinology, 1998, Internal Medicine, 1996

Awards:

Healthgrades Honor Roll

Languages:

English

Hospitals:

Endo Prctc Grp Strn Mem Hosp
601 Elmwood Ave, Rochester 14642
University Rochester Med Ct-End
601 Elmwood Ave SUITE 693, Rochester 14642
Strong Memorial Hospital
601 Elmwood Ave, Rochester 14642

Education:

Medical School
Duke University
Graduated: 1992
U Calif

Paxillin As A Therapeutic Or Diagnostic Marker For Cancer

US Patent:

2013013, May 30, 2013

Filed:

Jun 20, 2011

Appl. No.:

13/805298

Inventors:

Stephen R. Hammes - Rochester NY, US
Aritro Sen - Rochester NY, US

Assignee:

UNIVERSITY OF ROCHESTER - Rochester NY

International Classification:

G01N 33/68, A61K 31/7088

US Classification:

4241721, 436501, 514 44 A, 536 245, 5303917, 435 71

Abstract:

The present invention relates to methods for assessing the aggressiveness or proliferative activity of a cancer that is capable of both androgen-dependent and steroid-independent growth and proliferation; as well as methods and therapeutic agents for the treatment of such cancers including, among others, prostate cancers, testicular cancers, breast cancers, endometrial cancers, uterine cancers, and ovarian cancers.